Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:EXK - CA29258Y1034 - Common Stock

11.17 USD
+0.55 (+5.18%)
Last: 1/12/2026, 8:04:00 PM
11.25 USD
+0.08 (+0.72%)
Pre-Market: 1/13/2026, 5:16:58 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EXK. EXK was compared to 157 industry peers in the Metals & Mining industry. EXK may be in some trouble as it scores bad on both profitability and health. EXK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EXK had negative earnings in the past year.
EXK had a positive operating cash flow in the past year.
Of the past 5 years EXK 4 years were profitable.
In the past 5 years EXK always reported a positive cash flow from operatings.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

EXK has a Return On Assets of -9.27%. This is in the lower half of the industry: EXK underperforms 68.79% of its industry peers.
Looking at the Return On Equity, with a value of -18.53%, EXK is doing worse than 67.52% of the companies in the same industry.
With a Return On Invested Capital value of 0.08%, EXK perfoms like the industry average, outperforming 47.13% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EXK is significantly below the industry average of 10.34%.
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROIC 0.08%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

EXK has a Operating Margin (0.23%) which is in line with its industry peers.
In the last couple of years the Operating Margin of EXK has declined.
EXK's Gross Margin of 13.03% is in line compared to the rest of the industry. EXK outperforms 44.59% of its industry peers.
In the last couple of years the Gross Margin of EXK has declined.
Industry RankSector Rank
OM 0.23%
PM (TTM) N/A
GM 13.03%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXK is destroying value.
The number of shares outstanding for EXK has been increased compared to 1 year ago.
The number of shares outstanding for EXK has been increased compared to 5 years ago.
The debt/assets ratio for EXK is higher compared to a year ago.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

EXK has an Altman-Z score of 3.50. This indicates that EXK is financially healthy and has little risk of bankruptcy at the moment.
EXK has a Altman-Z score of 3.50. This is comparable to the rest of the industry: EXK outperforms 50.32% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that EXK is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.23, EXK is in line with its industry, outperforming 47.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 3.5
ROIC/WACC0.01
WACC9.2%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.79 indicates that EXK may have some problems paying its short term obligations.
EXK has a Current ratio of 0.79. This is amonst the worse of the industry: EXK underperforms 89.17% of its industry peers.
EXK has a Quick Ratio of 0.79. This is a bad value and indicates that EXK is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.57, EXK is not doing good in the industry: 85.99% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.57
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

EXK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -66.67%.
The Revenue has grown by 49.22% in the past year. This is a very strong growth!
Measured over the past years, EXK shows a quite strong growth in Revenue. The Revenue has been growing by 12.33% on average per year.
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%

3.2 Future

The Earnings Per Share is expected to grow by 61.79% on average over the next years. This is a very strong growth
Based on estimates for the next years, EXK will show a very strong growth in Revenue. The Revenue will grow by 39.07% on average per year.
EPS Next Y-13.62%
EPS Next 2Y203.95%
EPS Next 3Y116.02%
EPS Next 5Y61.79%
Revenue Next Year106.87%
Revenue Next 2Y84.24%
Revenue Next 3Y58.14%
Revenue Next 5Y39.07%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

EXK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
EXK is valuated rather expensively with a Price/Forward Earnings ratio of 19.29.
Based on the Price/Forward Earnings ratio, EXK is valued a bit cheaper than the industry average as 62.42% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of EXK to the average of the S&P500 Index (23.98), we can say EXK is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 19.29
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

EXK's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 61.93
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

EXK's earnings are expected to grow with 116.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y203.95%
EPS Next 3Y116.02%

0

5. Dividend

5.1 Amount

EXK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ENDEAVOUR SILVER CORP

NYSE:EXK (1/12/2026, 8:04:00 PM)

Premarket: 11.25 +0.08 (+0.72%)

11.17

+0.55 (+5.18%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners55.15%
Inst Owner Change0%
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap3.29B
Revenue(TTM)337.14M
Net Income(TTM)-94.29M
Analysts80
Price Target10.73 (-3.94%)
Short Float %6.7%
Short Ratio1.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-354.6%
Min EPS beat(2)-595.05%
Max EPS beat(2)-114.14%
EPS beat(4)1
Avg EPS beat(4)-1434.73%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-1023.35%
EPS beat(12)2
Avg EPS beat(12)-714.54%
EPS beat(16)3
Avg EPS beat(16)-577.87%
Revenue beat(2)2
Avg Revenue beat(2)8.49%
Min Revenue beat(2)0.04%
Max Revenue beat(2)16.94%
Revenue beat(4)3
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)16.94%
Revenue beat(8)7
Avg Revenue beat(8)2.97%
Revenue beat(12)9
Avg Revenue beat(12)1.92%
Revenue beat(16)10
Avg Revenue beat(16)-0.39%
PT rev (1m)10.29%
PT rev (3m)36.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)53.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-357.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)10.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.29
P/S 9.75
P/FCF N/A
P/OCF 69.95
P/B 6.46
P/tB 6.46
EV/EBITDA 61.93
EPS(TTM)-0.15
EYN/A
EPS(NY)0.58
Fwd EY5.18%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)0.16
OCFY1.43%
SpS1.15
BVpS1.73
TBVpS1.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROCE 0.1%
ROIC 0.08%
ROICexc 0.08%
ROICexgc 0.08%
OM 0.23%
PM (TTM) N/A
GM 13.03%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexgc growth 3Y-31.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 2.06
Cap/Depr 321.73%
Cap/Sales 52.32%
Interest Coverage 0.06
Cash Conversion 84.51%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.57
Altman-Z 3.5
F-Score3
WACC9.2%
ROIC/WACC0.01
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
EPS Next Y-13.62%
EPS Next 2Y203.95%
EPS Next 3Y116.02%
EPS Next 5Y61.79%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%
Revenue Next Year106.87%
Revenue Next 2Y84.24%
Revenue Next 3Y58.14%
Revenue Next 5Y39.07%
EBIT growth 1Y-91.44%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year123.81%
EBIT Next 3Y140.25%
EBIT Next 5Y60.94%
FCF growth 1Y-134.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.01%
OCF growth 3Y-6.61%
OCF growth 5YN/A

ENDEAVOUR SILVER CORP / EXK FAQ

What is the ChartMill fundamental rating of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EXK.


What is the valuation status of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a valuation rating of 2 / 10 to ENDEAVOUR SILVER CORP (EXK). This can be considered as Overvalued.


How profitable is ENDEAVOUR SILVER CORP (EXK) stock?

ENDEAVOUR SILVER CORP (EXK) has a profitability rating of 2 / 10.


Can you provide the financial health for EXK stock?

The financial health rating of ENDEAVOUR SILVER CORP (EXK) is 2 / 10.


What is the expected EPS growth for ENDEAVOUR SILVER CORP (EXK) stock?

The Earnings per Share (EPS) of ENDEAVOUR SILVER CORP (EXK) is expected to decline by -13.62% in the next year.